Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika
2024-10-02 20:00
Zepp Regains Compliance with NYSE Minimum Price Continued Listing Criterion
2024-10-02 19:00
Baird Medical and ExcelFin Acquisition Corp Complete Business Combination
2024-10-02 05:37
PeptiGrowth Inc. is Launching a Novel Synthetic FGF2 Alternative Peptide (FGFR1c Agonist)
2024-10-01 21:00
Digital & Intelligent Pathway: Xiaohongshu and VOGUE Business Unveil Groundbreaking Lifestyle Marketing Insights at Milan Summit
2024-09-30 16:50
Xiaohongshu x VOGUE Business Unveils New Horizons in Healthcare and Wellness at Milan Summit
2024-09-30 16:30
NUS researchers develop revolutionary technology to unravel complex protein interactions that could transform cancer diagnostics
2024-09-30 15:51
Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of Severe Hypertriglyceridemia
2024-09-30 15:00
IASO Bio Scientist and Leading Chinese Physicians in Onco-Hematology Visit Hematology Center at the State University of Campinas, Brazil, to Explore Cooperation in Cancer Treatment
2024-09-30 13:48
Akeso's Cadonilimab Receives Second Indication Approval from NMPA for First-Line Treatment of Gastric/GEJ Cancer in All-Comers Population
2024-09-30 13:42
World's First Carbon Neutral Salad: The Revolutionary Drinkable Salad that's Good for You and the Planet
2024-09-30 13:22
Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor's Portfolio of next-generation CDK inhibitors for the Treatment of Breast Cancer
2024-09-30 13:00
IASO Bio Presented Comparative Clinical Outcomes on the Optimal Lymphodepletion Prior to Infution of Equecabtagene Autoleucel(FucasoTM)in Patients with Relapsed Refractory Multiple Myeloma at 2024 IMS Annual Meeting
2024-09-29 21:00
SeromYx Systems and ACROBiosystems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies
2024-09-29 21:00
New Beginnings, New Journey | Sanyou Opening of New 10,000-sqm Facility, Ushering in a New Era of Innovation for Bio Drugs
2024-09-28 20:00
111, Inc. Announces Receipt of Notification from Nasdaq
2024-09-28 05:00
Ping An Healthcare and Technology Stock Soared 10% - Managed Care Takes Center Stage in Corporate Health Management
2024-09-27 21:12
Concord Medical Reports Financial Results for the First Half of 2024
2024-09-27 19:00
25 Years of Innovation and Excellence: Alma Celebrates Silver Anniversary at the Seventh Alma Academy Event in Thailand
2024-09-27 17:00
IASO Bio Presented the Outcomes of Relapsed/Refractory Multiple Myeloma (R/RMM) Patients with Renal Impairment Treated with Equecabtagene Autoleucel (Fucaso™) at 2024 IMS Annual Meeting
2024-09-27 15:41
1
17
18
19
20
21
807